Search research articles
Contact Us
Filters
Showing results (51-60 of 563) with videos related to
Page
of 57
Sort By:
Antiviral Research
|
May 1, 1989
Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivo
J Balzarini, P Herdewijn, E De Clercq
Biochemical Pharmacology
|
June 1, 1989
Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase
E De Clercq, M Cools, J Balzarini
Gene Therapy
|
October 6, 2000
Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV)
B Degrève, E De Clercq, J Balzarini
Current Opinion in Microbiology
|
March 6, 1999
New antivirals - mechanism of action and resistance development
J Balzarini, L Naesens, E De Clercq
Molecular Pharmacology
|
November 6, 1998
Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line
S Hatse, E De Clercq, J Balzarini
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Design and synthesis of bio-isosteres of thymidine triphosphate
A O Goldring, J Balzarini, I H Gilbert
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK
N Solaroli, M Johansson, J Balzarini, et al.
Gene Therapy
|
August 4, 2006
Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants
N Solaroli, M Johansson, J Balzarini, et al.
Biochemical Pharmacology
|
July 19, 1994
Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice
M Weibel, J Balzarini, A Bernhardt, et al.
Molecular Pharmacology
|
March 1, 1990
Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds
J Balzarini, R Bernaerts, A Verbruggen, et al.
Page
of 57
Search research articles
Search
Showing results (51-60 of 563) with videos related to
Sort By:
Page
of 57
Antiviral Research
|
May 1, 1989
Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivo
J Balzarini, P Herdewijn, E De Clercq
Biochemical Pharmacology
|
June 1, 1989
Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase
E De Clercq, M Cools, J Balzarini
Gene Therapy
|
October 6, 2000
Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV)
B Degrève, E De Clercq, J Balzarini
Current Opinion in Microbiology
|
March 6, 1999
New antivirals - mechanism of action and resistance development
J Balzarini, L Naesens, E De Clercq
Molecular Pharmacology
|
November 6, 1998
Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line
S Hatse, E De Clercq, J Balzarini
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Design and synthesis of bio-isosteres of thymidine triphosphate
A O Goldring, J Balzarini, I H Gilbert
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK
N Solaroli, M Johansson, J Balzarini, et al.
Gene Therapy
|
August 4, 2006
Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants
N Solaroli, M Johansson, J Balzarini, et al.
Biochemical Pharmacology
|
July 19, 1994
Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice
M Weibel, J Balzarini, A Bernhardt, et al.
Molecular Pharmacology
|
March 1, 1990
Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds
J Balzarini, R Bernaerts, A Verbruggen, et al.
Page
of 57